New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
Source : https://pubmed.ncbi.nlm.nih.gov/38576614/
Oncolytic virus (OV) therapy has emerged as a promising frontier in cancer treatment, especially for solid tumours. While immunotherapies like immune checkpoint inhibitors and CAR-T cells have demonstrated impressive results,...
Oncolytic viruses (OVs) show potential in breast cancer therapy, especially when combined with other treatments, improving outcomes despite current challenges in monotherapy efficacy and safety.
LCN2: Versatile players in breast cancer
Source : https://pubmed.ncbi.nlm.nih.gov/38171248/
Lipocalin 2 (LCN2) is a secreted glycoprotein that is produced by immune cells, including neutrophils and macrophages. It serves various functions such as transporting hydrophobic ligands across the cellular membrane,...
Lipocalin 2 (LCN2) is critical in breast cancer progression, influencing cell proliferation, apoptosis, and resistance to therapy, making it a promising target for future therapeutic strategies.
HER2-Low Breast Cancer: Now and in the Future
Source : https://pubmed.ncbi.nlm.nih.gov/38291745/
Breast cancer is a heterogeneous disease, and its subtypes are characterized by hormone receptor and human epidermal growth factor receptor 2 (HER2) expression status. "HER2-low" tumors, which exhibit a low...
HER2-low breast cancer, previously deemed untreatable with anti-HER2 agents, shows promising responses to new therapies like trastuzumab-deruxtecan, emphasizing the need for further biological and prognostic research.
Male Breast Cancer: Imaging Considerations for Diagnosis and Surveillance
Source : https://pubmed.ncbi.nlm.nih.gov/38855781/
Male breast cancer accounts for less than 1% of all breast cancer cases. The important risk factors for the development of male breast cancer are family history, genetic mutations, obesity,...
Addressing the gaps in current research, this review provides crucial insights into imaging considerations, timing, prognostication, and follow-up strategies for male breast cancer, offering valuable guidance for clinical management.
Traditional Chinese medicine for breast cancer treatment: a bibliometric and visualization analysis
Source : https://pubmed.ncbi.nlm.nih.gov/38813803/
A total of 1080 English publications and 2617 Chinese publications were included in the analysis. China was the leading contributor of publications. High-frequency keywords such as 'apoptosis', 'expression', ' in...
The development of modern science, technology, and in-depth research can result in broader prospects for the research and application of TCM in breast cancer treatment, resulting in more effective solutions for the treatment of breast cancer and other malignant tumors.